CNTN2 and adult T-cell leukemia/lymphoma: Individuals expressing HLA class I related to the predisposition to the development of ATLL (HLA-A*26, HLA-B*402, HLA-B406 e, HLA-B*4801), exhibit modified peptide binding sites that are unable to recognize different HTLV-1 Tax protein peptides.